Search hospitals > Ohio > Akron
Cleveland Clinic Akron General
Claim this profileAkron, Ohio 44307
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
240 reported clinical trials
10 medical researchers
Summary
Cleveland Clinic Akron General is a medical facility located in Akron, Ohio. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Cleveland Clinic Akron General is involved with conducting 240 clinical trials across 320 conditions. There are 10 research doctors associated with this hospital, such as Kathryn M. Leininger, Esther H. Rehmus, Ashok Ramalingam, and Judy Peih-Ying Tsai.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Kathryn M. LeiningerCleveland Clinic Akron General4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
16 reported clinical trials
34 drugs studied
Esther H. RehmusCleveland Clinic Akron General9 years of reported clinical research
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
28 drugs studied
Ashok RamalingamCleveland Clinic Akron General8 years of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
9 reported clinical trials
31 drugs studied
Judy Peih-Ying TsaiCleveland Clinic Akron General4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
25 drugs studied
Clinical Trials running at Cleveland Clinic Akron General
Prostate Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Squamous Cell Carcinoma
Small Cell Lung Cancer
Cancer
Colorectal Cancer
Pancreatic Cancer
Recurrence
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cleveland Clinic Akron General?
Cleveland Clinic Akron General is a medical facility located in Akron, Ohio. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Cleveland Clinic Akron General is involved with conducting 240 clinical trials across 320 conditions. There are 10 research doctors associated with this hospital, such as Kathryn M. Leininger, Esther H. Rehmus, Ashok Ramalingam, and Judy Peih-Ying Tsai.